Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior in Vitro

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Giusti, Ilaria ^a   D'Ascenzo, Sandra ^a   Mancò, Annalisa ^a   Di Stefano, Gabriella ^a   Di Francesco, Marianna ^a   Rughetti, Anna ^b   Dal Mas, Antonella ^b   Properzi, Gianfranco ^a   Calvisi, Vittorio ^a   Dolo, Vincenza ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; THROMBOCYTE CONCENTRATE; COLLAGEN; SIGNAL PEPTIDE;

ACHILLES TENDINITIS; ACHILLES TENDON; ADULT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLS BY BODY ANATOMY; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PROTEIN DEGRADATION; ROTATOR CUFF; SUPERNATANT; TENDON; TENOCYTE; THROMBOCYTE; THROMBOCYTE RICH PLASMA; WESTERN BLOTTING; ZYMOGRAPHY; CELL MOTION; METABOLISM; PHYSIOLOGY; WOUND HEALING;

ADULT; BLOOD PLATELETS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PLATELET-RICH PLASMA; TENDONS; WOUND HEALING;

EID: 84921808918     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/630870     Document Type: Article

References (56)

1. W. S. Pietrzak and B. L. Eppley, "Platelet rich plasma: biology and new technology, " Journal of Craniof acial Surgery, vol. 16, no. 6, pp. 1043-1054, 2005.
2. C. E. Sommeling, A. Heyneman, H. Hoeksema, J. Verbelen, F. B. Stillaert, and S. Monstrey, "The use of platelet-rich plasma in plastic surgery: a systematic review, " Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 66, no. 3, pp. 301-311, 2013.
3. M. de Mos, A. E. van der Windt, H. Jahr, et al., "Can plateletrich plasma enhance tendon repair? A cell culture study, " The AmericanJournal of SportsMedicine, vol. 36, no. 6, pp. 1171-1178, 2008.
4. B. L. Eppley, J. E. Woodell, and J. Higgins, "Platelet quantificationand growth factor analysis fromplatelet-richplasma: implications for wound healing, " Plastic and Reconstructive Surgery, vol. 114, no. 6, pp. 1502-1508, 2004.
5. I. Giusti, A. Rughetti, S. DAscenzo, et al., "The effects of platelet gel-released supernatant on human fibroblasts, " Wound Repair and Regeneration, vol. 21, no. 2, pp. 300-308, 2013.
6. T. E. Foster, B. L. Puskas, B. R. Mandelbaum, M. B. Gerhardt, and S. A. Rodeo, "Platelet-rich plasma: from basic science to clinical applications, " American Journal of Sports Medicine, vol. 37, no. 11, pp. 2259-2272, 2009.
7. R. Landesberg, A. Burke, D. Pinsky, et al., "Activation of plateletrich plasma using thrombin receptor agonist peptide, " Journal of Oral and Maxillof acial Surgery, vol. 63, no. 4, pp. 529-535, 2005.
8. I. Giusti, A. Rughetti, S. DAscenzo, et al., "Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells, " Transfusion, vol. 49, no. 4, pp. 771-778, 2009.
9. A. S. Wasterlain, H. J. Braun, A. H. S. Harris, H. Kim, and J. L. Dragoo, "The systemic effects of platelet-rich plasma injection, " The American Journal of Sports Medicine, vol. 41, no. 1, pp. 186-193, 2013.
10. L. V. Schnabel, H. O. Mohammed, B. J. Miller, et al., "Platelet Rich Plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons, " Journal of Orthopaedic Research, vol. 25, no. 2, pp. 230-240, 2007.
11. G. Schippinger, K. Oettl, F. Fankhauser, S. Spirk, W. Domej, and P. Hofmann, "Influence of intramuscular application of autologous conditioned plasma on systemic circulating IGF-1, " Journal of Sports Science and Medicine, vol. 10, no. 3, pp. 439-444, 2011.
12. B. L. Eppley, J. E. Woodell, and J. Higgins, "Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing, " Plastic and Reconstructive Surgery, vol. 114, no. 6, pp. 1502-1508, 2004.
13. C. J. Rosen and M. Pollak, "Circulating a newcentury, " Trends in Endocrinology and Metabolism, vol. 10, no. 4, pp. 136-141, 1999.
14. S. Mehta and J. T. Watson, "Platelet rich concentrate: basic science and current clinical applications, " Journal of Orthopaedic Trauma, vol. 22, no. 6, pp. 432-438, 2008.
15. S. E. Smith and T. S. Roukis, "Bone and wound healing augmentation with platelet-rich plasma, " Clinics in Podiatric Medicine and Surgery, vol. 26, no. 4, pp. 559-588, 2009.
16. N. Maffulli, U. G. Longo, and V. Denaro, "Novel approaches for the management of tendinopathy, " Journal of Bone and Joint Surgery, vol. 92, no. 15, pp. 2604-2613, 2010.
17. T. Molloy, Y. Wang, and G. A. C. Murrell, "The roles of growth factors in tendon and ligament healing, " Sports Medicine, vol. 33, no. 5, pp. 381-394, 2003.
18. E. V. Cheung, L. Silverio, and J. W. Sperling, "Strategies in biologic augmentation of rotator cuff repair: a review, " Clinical Orthopaedics and Related Research, vol. 468, no. 6, pp. 1476-1484, 2010.
19. X. Wang, Y. Qiu, J. Triffitt, A. Carr, Z. Xia, and A. Sabokbar, "Proliferation and differentiation of human tenocytes in response to platelet rich plasma: an in vitro and in vivo study, " Journal of Orthopaedic Research, vol. 30, no. 6, pp. 982-990, 2012.
20. R. J. De Vos, A. Weir, H. T. M. Van Schie, et al., "Plateletrich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial, " Journal of the American Medical Association, vol. 303, no. 2, pp. 144-149, 2010.
21. M. Sanchez, E. Anitua, G. Orive, I. Mujika, and I. Andia, "Platelet-rich therapies in the treatment of orthopaedic sport injuries, " Sports Medicine, vol. 39, no. 5, pp. 345-354, 2009.
22. N. Zargar Baboldashti, R. C. Poulsen, S. L. Franklin, M. S. Thompson, and P. A. Hulley, "Platelet-rich plasma protects tenocytes from adverse side effects of dexamethasone and ciprof loxacin, " The American Journal of SportsMedicine, vol. 39, no. 9, pp. 1929-1935, 2011.
23. P. Aspenberg and O. Virchenko, "Platelet concentrate injection improves Achilles tendon repair in rats, " Acta Orthopaedica Scand inavica, vol. 75, no. 1, pp. 93-99, 2004.
24. D. N. Lyras, K. Kazakos, D. Verettas, et al., "The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing, " Foot and Ankle International, vol. 30, no. 11, pp. 1101-1106, 2009.
25. G. Bosch, M. Moleman, A. Barneveld, P. R. vanWeeren, and H. T. M. van Schie, "The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions, " Scand inavian Journal of Medicine and Science in Sports, vol. 21, no. 4, pp. 554-561, 2011.
26. J. G. Lane, R. M. Healey, D. C. Chase, and D. Amiel, "Use of platelet-rich plasma to enhance tendon function and cellularity, " The American Journal of Orthopedics, vol. 42, no. 5, pp. 209-214, 2013.
27. M. Sanchez, E. Anitua, J. Azofra, I. Anda, S. Padilla, and I. Mujika, "Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices, " American Journal of Sports Medicine, vol. 35, no. 2, pp. 245-251, 2007.
28. K. Gaweda, M. Tarczynska, and W. Krzyzanowski, "Treatment of achilles tendinopathy with platelet-rich plasma, " International Journal of SportsMedicine, vol. 31, no. 8, pp. 577-583, 2010.
29. K. Harmon, J. Drezner, and A. Rao, "Platelet rich plasma for chronic tendinopathy, " British Journal of Sports Medicine, vol. 47, p. e2, 2013.
30. S. de Jonge, R. J. de Vos, A. Weir, et al., "One-year follow-up of platelet-rich plasma treatment in chronic achilles tendinopathy: a double-blind randomized placebo-controlled trial, " American Journal of Sports Medicine, vol. 39, no. 8, pp. 1623-1629, 2011.
31. T. Schepull, J. Kvist, H. Norrman, M. Trinks, G. Berlin, and P. Aspenberg, "Autologous platelets have no effect on the healing of human Achilles tendon ruptures: a randomized single-blind study, " The American Journal of Sports Medicine, vol. 39, no. 1, pp. 38-47, 2011.
32. J. Chahal, G. S. van Thiel, N. Mall, et al., "The role of platelet-rich plasma in arthroscopic rotator cuff repair: a systematic review with quantitative synthesis, " Arthroscopy-Journal of Arthroscopic and Related Surgery, vol. 28, no. 11, pp. 1718-1727, 2012.
33. J. Kaux and J. Crielaard, "Platelet-rich plasma application in themanagement of chronic tendinopathies, " Acta Orthopaedica Belgica, vol. 79, no. 1, pp. 10-15, 2013.
34. E. Anitua, I. Anda, M. Sanchez, et al., "Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture, " Journal of Orthopaedic Research, vol. 23, no. 2, pp. 281-286, 2005.
35. C. H. Jo, J. E. Kim, K. S. Yoon, and S. Shin, "Platelet-rich plasma stimulates cell proliferation and enhances matrix gene expression and synthesis in tenocytes from human rotator cuff tendonswith degenerative tears, "TheAmerican Journal of Sports Medicine, vol. 40, no. 5, pp. 1035-1045, 2012.
36. A. D. Mazzocca, M. B. R. McCarthy, D. M. Chowaniec, et al., "The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells, " American Journal of Sports Medicine, vol. 40, no. 8, pp. 1742-1749, 2012.
37. A. Rughetti, I. Giusti, S. DAscenzo, et al., "Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells, " Blood Transfusion, vol. 6, no. 1, pp. 12-17, 2008.
38. P. Sharma and N. Maffulli, "Tendon injury and tendinopathy: Healing and repair, " Journal of Bone and Joint Surgery A, vol. 87, no. 1, pp. 187-202, 2005.
39. R. James, G. Kesturu, G. Balian, and A. B. Chhabra, "Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options, " The Journal of Hand Surgery, vol. 33, no. 1, pp. 102-112, 2008.
40. M. Vetrano, F. dAlessandro, M. R. Torrisi, A. Ferretti, M. C. Vulpiani, and V. Visco, "Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes, " Knee Surgery, Sports Traumatology, Arthroscopy, vol. 19, no. 12, pp. 2159-2168, 2011.
41. L. J. Backman, G. Fong, G. Andersson, et al., "Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation, " PLoS ONE, vol. 6, no. 11, Article ID e27209, 2011.
42. R. Schweitzer, J. H. Chyung, L. C. Murtaugh, et al., "Analysis of the tendon cell fate using scleraxis, a specific marker for tendons and ligaments, " Development, vol. 128, no. 19, pp. 3855-3866, 2001.
43. S. Pauly, F. Klatte, C. Strobel, et al., "Characterization of tendon cell cultures of the human rotator cuff, " European Cells and Materials, vol. 20, pp. 84-97, 2010.
44. V. Lejard, G. Brideau, F. Blais, et al., "Scleraxis and NFATc regulate the expression of the pro-β1(I) collagen gene in tendon fibroblasts, "The Journal of Biological Chemistry, vol. 282, no. 24, pp. 17665-17675, 2007.
45. P. Cserjesi, D. Brown, K. L. Ligon, et al., "Scleraxis: A basic helixloop-helix protein that prefigures skeletal formation during mouse embryogenesis, " Development, vol. 121, no. 4, pp. 1099-1110, 1995.
46. M. A. Akhavani, B. Sivakumar, E. M. Paleolog, and N. Kang, "Angiogenesis and plastic surgery, " Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 61, no. 12, pp. 1425-1437, 2008.
47. D. Lyras, K. Kazakos, D. Verettas, et al., "Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect, " International Orthopaedics, vol. 34, no. 1, pp. 143-148, 2010.
48. T. M. Ritty and J. Herzog, "Tendon cells produce gelatinases in response to type I collagen attachment, " Journal of Orthopaedic Research, vol. 21, no. 3, pp. 442-450, 2003.
49. W. Oshiro, J. Lou, X. Xing, Y. Tu, and P. R. Manske, "Flexor tendon healing in the rat: a histologic and gene expression study, " Journal of Hand Surgery, vol. 28, no. 5, pp. 814-823, 2003.
50. P. Kannus, "Structure of the tendon connective tissue, " Scand inavian Journal of Medicine and Science in Sports, vol. 10, no. 6, pp. 312-320, 2000.
51. G. P. Riley, "Gene expression and matrix turnover in overused and damaged tendons, " Scand inavian Journal of Medicine & Science in Sports, vol. 15, no. 4, pp. 241-251, 2005.
52. G. Gross and A. Hoffmann, "Therapeutic strategies for tendon healing based on novel biomaterials, factors and cells, " Pathobiology, vol. 80, no. 4, pp. 203-210, 2013.
53. H. Qiao, J. Bell, S. Juliao, L. Li, and J. M. May, "Ascorbic acid uptake and regulation of type I collagen synthesis in cultured vascular smoothmuscle cells, " Journal of Vascular Research, vol. 46, no. 1, pp. 15-24, 2008.
54. R. A. Bagchi and M. P. Czubryt, "Synergistic roles of scleraxis and Smads in the regulation of collagen 1β2 gene expression, " Biochimicaet Biophysica Acta-Molecular Cell Research, vol. 1823, no. 10, pp. 1936-1944, 2012.
55. Y. M. Farhat, A. A. Al-Maliki, T. Chen, et al., "Gene expression analysis of the pleiotropic effects of TGF-β1 in an in vitromodel of flexor tendon healing, " PLoS ONE, vol. 7, no. 12, Article ID e51411, 2012.
56. Y. Liu, P. Cserjesi, A. Nifuji, E. N. Olson, and M. Noda, "Sclerotome-related helix-loop-helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-β transforming growth factor, " Journal of Endocrinology, vol. 151, no. 3, pp. 491-499, 1996.